Home/Filings/4/0001104659-21-020672
4//SEC Filing

Sabba Stephen L 4

Accession 0001104659-21-020672

CIK 0000886163other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 4:06 PM ET

Size

14.5 KB

Accession

0001104659-21-020672

Insider Transaction Report

Form 4
Period: 2021-02-09
Transactions
  • Exercise/Conversion

    Common Stock

    2021-02-09$10.12/sh+7,335$74,23031,766 total
  • Exercise/Conversion

    Common Stock

    2021-02-09$12.53/sh+7,335$91,90839,101 total
  • Sale

    Common Stock

    2021-02-09$208.00/sh556$115,64838,545 total
  • Sale

    Common Stock

    2021-02-09$208.55/sh14,114$2,943,47524,431 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2021-02-097,3350 total
    Exercise: $10.12Exp: 2021-06-01Common Stock (7,335 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2021-02-097,3350 total
    Exercise: $12.53Exp: 2022-05-31Common Stock (7,335 underlying)
Footnotes (3)
  • [F1]These securities, as represented in Column 5, include a grant of 831 restricted shares approved by the Board of Directors of the Company at the 2020 Meeting, which shares were previously reported on a Form 4 for this Reporting Person filed on June 12, 2020, and are included on this Form 4 only to report that they will vest in full within six (6) months from the date hereof.
  • [F2]These securities, as represented in Column 5, were acquired by a grant of 7,335 shares approved by the Board of Directors of the Company at the 2011 Meeting and are fully vested and exerciseable as more fully described on a Form 4 for this Reporting Person filed on June 6, 2011.
  • [F3]These securities, as represented in Column 5, were acquired by a grant of 7,335 shares approved by the Board of Directors of the Company at the 2012 Meeting and are fully vested and exerciseable as more fully described on a Form 4 for this Reporting Person filed on June 4, 2012.

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001442372

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:06 PM ET
Size
14.5 KB